Liquidia LQDA
NASDAQ LQDA
$69.12 +1.44 (+2.13%)
As of: Sep 9, 2026 · 3:59 PM EDT

Liquidia (LQDA) Net Shares Issued and Repurchased (2020 - 2026)

Liquidia (LQDA) posted Net Shares Issued and Repurchased of $32548.0 for Q1 2026, down 75.32% on a QoQ basis from $131867.0 in Q4 2025.

Analysis

Liquidia (LQDA) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends

Liquidia has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $32548.0 in Q1 2026.

  • On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $32548.0 in Q1 2026; TTM through Mar 2026 was $32548.0, a N/A change from a year earlier, with the FY2025 full-year figure at $131867.0, down 31.44% from the prior year.
  • Net Shares Issued and Repurchased was $32548.0 for Q1 2026 at Liquidia, down from $131867.0 in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $4.5 million in Q4 2022, with the low at $7500.0 in Q1 2024.
  • Average Net Shares Issued and Repurchased over 5 years is $1.2 million, with a median of $668241.0 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased jumped 121.81% in 2022, then slumped 99.34% in 2024.
  • Over 5 years, Net Shares Issued and Repurchased stood at $4.5 million in 2022, then sank by 67.39% to $1.5 million in 2023, then plunged by 86.86% to $192336.0 in 2024, then sank by 31.44% to $131867.0 in 2025, then slumped by 75.32% to $32548.0 in 2026.
  • The last three Net Shares Issued and Repurchased figures came in at $32548.0 (Q1 2026), $131867.0 (Q4 2025), and $192336.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -3.07 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Liquidia 6.14 Bn 5.86 Bn 160.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 32,548.00
Dec 31, 2025 131,867.00
Dec 31, 2024 192,336.00
Mar 31, 2024 7,500.00
Dec 31, 2023 1.46 Mn
Mar 31, 2023 1.14 Mn
Dec 31, 2022 4.49 Mn
Mar 31, 2022 2.46 Mn
Dec 31, 2021 2.02 Mn
Mar 31, 2021 1.16 Mn
Dec 31, 2020 2.00 Mn